Focus: Gamma Vaccines is a private Australian biotech focused on broad-spectrum vaccines targeting human and animal viruses in the infectious diseases space. The company is early-stage with a small active hiring footprint (21 open roles) and limited public visibility.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Stable — net -3 jobs in 30d
3 added, 6 removed. Backfill posture.
Gamma Vaccines is a speculative, early-stage play suited only for risk-tolerant professionals seeking founder-level equity upside and technical infrastructure roles; traditional pharma scientists should seek companies with visible pipeline and financial runway.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Gamma Vaccines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Gamma Vaccines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo